Sex differences in survival after out-of-hospital cardiac arrest: a meta-analysis

Hao Lei1, Jiahui Hu1, Leiling Liu1

  • 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, 410011, Hunan, China.

Insights

This meta-analysis found that females experiencing out-of-hospital cardiac arrest (OHCA) have lower survival rates and poorer neurological outcomes compared to males. These sex differences in OHCA prognosis warrant further investigation into underlying causes and treatment strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Emergency Medicine

Background:

  • Out-of-hospital cardiac arrest (OHCA) is a significant global cause of sudden cardiac death.
  • Existing research indicates sex-based pathophysiological and clinical differences in OHCA, yet consensus on survival and prognosis disparities remains elusive.

Purpose of the Study:

  • To investigate the relationship between sex factors and prognosis in patients with OHCA.
  • To clarify existing discrepancies in the literature regarding sex differences in OHCA outcomes.

Main Methods:

  • A comprehensive meta-analysis was conducted, searching PubMed, Embase, and Cochrane databases.
  • 33 studies involving 1,268,664 patients were included, with pooled odds ratios (ORs) and 95% confidence intervals (CIs) estimated using a random-effects model.

Main Results:

  • Females with OHCA were older and more likely to experience unwitnessed arrests compared to males.
  • While survival to hospital admission showed no significant sex difference, females had significantly lower survival rates from hospital admission to discharge (OR 0.59) and poorer neurological outcomes (OR 0.62).

Conclusions:

  • Females with OHCA exhibit lower overall survival and neurological prognosis compared to males.
  • Potential contributing factors include female pathophysiological characteristics, more conservative treatment approaches, and variations in post-resuscitation care.
  • Findings should be interpreted cautiously due to potential confounding factors in the included studies.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
448
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
372
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
286
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
319
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
557
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
330